PL3380104T3 - Ligand receptora adenozynowego a3 do zastosowania w leczeniu akumulacji tłuszczu ektopowego - Google Patents
Ligand receptora adenozynowego a3 do zastosowania w leczeniu akumulacji tłuszczu ektopowegoInfo
- Publication number
- PL3380104T3 PL3380104T3 PL16806299T PL16806299T PL3380104T3 PL 3380104 T3 PL3380104 T3 PL 3380104T3 PL 16806299 T PL16806299 T PL 16806299T PL 16806299 T PL16806299 T PL 16806299T PL 3380104 T3 PL3380104 T3 PL 3380104T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor ligand
- adenosine receptor
- fat accumulation
- ectopic fat
- treating ectopic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL242723A IL242723B (en) | 2015-11-23 | 2015-11-23 | A3 adenosine receptor ligand for the treatment of ectopic fat accumulation |
| PCT/IL2016/051258 WO2017090036A1 (en) | 2015-11-23 | 2016-11-22 | An a3 adenosine receptor ligand for use in treating ectopic fat accumulation |
| EP16806299.0A EP3380104B1 (en) | 2015-11-23 | 2016-11-22 | An a3 adenosine receptor ligand for use in treating ectopic fat accumulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3380104T3 true PL3380104T3 (pl) | 2021-08-02 |
Family
ID=57485841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16806299T PL3380104T3 (pl) | 2015-11-23 | 2016-11-22 | Ligand receptora adenozynowego a3 do zastosowania w leczeniu akumulacji tłuszczu ektopowego |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10780106B2 (pl) |
| EP (1) | EP3380104B1 (pl) |
| JP (2) | JP6980655B2 (pl) |
| KR (1) | KR102103657B1 (pl) |
| CN (1) | CN108367016B (pl) |
| BR (1) | BR112018010391A8 (pl) |
| CA (1) | CA3005961A1 (pl) |
| DK (1) | DK3380104T3 (pl) |
| ES (1) | ES2848150T3 (pl) |
| HR (1) | HRP20210020T1 (pl) |
| HU (1) | HUE053558T2 (pl) |
| IL (3) | IL242723B (pl) |
| LT (1) | LT3380104T (pl) |
| MX (1) | MX2018006026A (pl) |
| PL (1) | PL3380104T3 (pl) |
| PT (1) | PT3380104T (pl) |
| RS (1) | RS61372B1 (pl) |
| SI (1) | SI3380104T1 (pl) |
| WO (1) | WO2017090036A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL254535A0 (en) * | 2017-09-17 | 2017-11-30 | Can Fite Biopharma Ltd | Adenosine a3 receptor ligand for use in the management of cytokine release syndrome |
| IL264112A (en) * | 2019-01-06 | 2020-07-30 | Fishman Pnina | Adenosine a3 receptor ligand for use in lowering adipocyte levels |
| IL272078A (en) | 2020-01-16 | 2021-07-29 | Can Fite Biopharma Ltd | Cannabinoids for use in therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443836A (en) | 1993-03-15 | 1995-08-22 | Gensia, Inc. | Methods for protecting tissues and organs from ischemic damage |
| AU7331094A (en) | 1993-07-13 | 1995-02-13 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor agonists |
| US5688774A (en) | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| AU1399297A (en) | 1996-01-24 | 1997-08-20 | Sumitomo Chemical Company, Limited | Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production |
| US6048865A (en) | 1997-07-29 | 2000-04-11 | Medco Research, Inc. | N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator |
| WO1999006053A1 (en) | 1997-07-29 | 1999-02-11 | Medco Research, Inc. | N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| US6329349B1 (en) | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| ATE292973T1 (de) * | 2001-01-16 | 2005-04-15 | Can Fite Biopharma Ltd | Verwendung eines adenosin-a3-rezeptor-agonisten zur hemmung der virenreplikation |
| DK1983990T3 (da) | 2006-01-26 | 2011-07-11 | Us Gov Health & Human Serv | Allosteriske A3-adenosin-receptormodulatorer |
| CN101820883B (zh) | 2007-10-15 | 2013-03-20 | 坎-菲特生物药物有限公司 | A3ar激动剂在用于制备刺激肝细胞增殖的药物中的应用 |
| EP2806878A1 (en) * | 2012-01-23 | 2014-12-03 | Can-Fite Biopharma Ltd. | Treatment of liver conditions |
-
2015
- 2015-11-23 IL IL242723A patent/IL242723B/en active IP Right Grant
-
2016
- 2016-11-22 BR BR112018010391A patent/BR112018010391A8/pt not_active Application Discontinuation
- 2016-11-22 EP EP16806299.0A patent/EP3380104B1/en active Active
- 2016-11-22 PT PT168062990T patent/PT3380104T/pt unknown
- 2016-11-22 KR KR1020187016840A patent/KR102103657B1/ko active IP Right Grant
- 2016-11-22 CN CN201680068558.0A patent/CN108367016B/zh active Active
- 2016-11-22 LT LTEP16806299.0T patent/LT3380104T/lt unknown
- 2016-11-22 IL IL289841A patent/IL289841B/en unknown
- 2016-11-22 HU HUE16806299A patent/HUE053558T2/hu unknown
- 2016-11-22 ES ES16806299T patent/ES2848150T3/es active Active
- 2016-11-22 SI SI201631045T patent/SI3380104T1/sl unknown
- 2016-11-22 RS RS20210079A patent/RS61372B1/sr unknown
- 2016-11-22 MX MX2018006026A patent/MX2018006026A/es unknown
- 2016-11-22 PL PL16806299T patent/PL3380104T3/pl unknown
- 2016-11-22 DK DK16806299.0T patent/DK3380104T3/da active
- 2016-11-22 WO PCT/IL2016/051258 patent/WO2017090036A1/en active Application Filing
- 2016-11-22 CA CA3005961A patent/CA3005961A1/en active Pending
- 2016-11-22 JP JP2018526535A patent/JP6980655B2/ja active Active
-
2018
- 2018-05-16 IL IL259396A patent/IL259396B/en unknown
- 2018-05-22 US US15/986,332 patent/US10780106B2/en active Active
-
2020
- 2020-02-10 JP JP2020020917A patent/JP6990934B2/ja active Active
- 2020-08-26 US US17/003,191 patent/US11291681B2/en active Active
-
2021
- 2021-01-07 HR HRP20210020TT patent/HRP20210020T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL242723B (en) | 2019-12-31 |
| DK3380104T3 (da) | 2021-02-08 |
| JP6990934B2 (ja) | 2022-01-12 |
| PT3380104T (pt) | 2021-02-05 |
| KR102103657B1 (ko) | 2020-04-23 |
| CN108367016B (zh) | 2021-07-16 |
| LT3380104T (lt) | 2021-05-10 |
| IL242723A0 (en) | 2016-02-29 |
| IL289841A (en) | 2022-03-01 |
| CA3005961A1 (en) | 2017-06-01 |
| WO2017090036A1 (en) | 2017-06-01 |
| EP3380104A1 (en) | 2018-10-03 |
| US20200384009A1 (en) | 2020-12-10 |
| IL259396A (en) | 2018-07-31 |
| JP6980655B2 (ja) | 2021-12-15 |
| SI3380104T1 (sl) | 2021-05-31 |
| BR112018010391A8 (pt) | 2019-02-26 |
| RS61372B1 (sr) | 2021-02-26 |
| US20180264022A1 (en) | 2018-09-20 |
| BR112018010391A2 (pt) | 2018-11-21 |
| KR20180081595A (ko) | 2018-07-16 |
| US11291681B2 (en) | 2022-04-05 |
| IL289841B (en) | 2022-07-01 |
| JP2018534333A (ja) | 2018-11-22 |
| JP2020090532A (ja) | 2020-06-11 |
| IL259396B (en) | 2022-02-01 |
| MX2018006026A (es) | 2019-01-28 |
| ES2848150T3 (es) | 2021-08-05 |
| US10780106B2 (en) | 2020-09-22 |
| CN108367016A (zh) | 2018-08-03 |
| HUE053558T2 (hu) | 2021-07-28 |
| HRP20210020T1 (hr) | 2021-03-05 |
| EP3380104B1 (en) | 2020-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259242A (en) | A component for creating a spray for use in an item for creating a spray | |
| GB2559915B (en) | Resistive processing unit | |
| PT3666091T (pt) | Artigo para utilização em aparelho de aquecimento de material fumável | |
| IL248708A0 (en) | A system for creating a spray containing a multipurpose computing device | |
| IL259607B (en) | Inositol derivatives for use in pathological crystallization | |
| IL289841A (en) | A3 adenosine receptor ligand for use in the treatment of ectopic fat accumulation | |
| EP3362116C0 (en) | GREASE FILTRATION DEVICE | |
| GB2543759B (en) | Vehicle user advice system | |
| GB2559701B (en) | Hook apparatus | |
| HK1248642A1 (zh) | 功能墊賽車 | |
| IL260138A (en) | Nonwoven unit | |
| SG10201606767SA (en) | Direct resistivity determination | |
| PL2957328T3 (pl) | Układ mat sportowych | |
| ZA201802418B (en) | Process for preparing fat continuous emulsions low in fat | |
| GB201614656D0 (en) | Improvements in or relating to apparatus for cooking | |
| HK1216474A2 (zh) | 寵物廁所用墊 | |
| HUE056886T2 (hu) | Talaj szõnyeg elrendezés lovas terepekhez | |
| GB2544893B (en) | Grooming apparatus | |
| SG11201708809TA (en) | Squeegee device for cleaning | |
| GB201502486D0 (en) | Finishing system for 3D prints | |
| GB201516634D0 (en) | Design method for dosing unit | |
| GB201600365D0 (en) | Mat | |
| GB2537596B (en) | Weighing Apparatus | |
| GB201514731D0 (en) | System for use in steering apparatus |